Skip to main content

Transplanted hair follicle stem cells migrate to the penumbra and express neural markers in a rat model of cerebral ischaemia/reperfusion

Abstract

Background

Ischaemic stroke has become the main cause of death and severe neurological disorders, for which effective restorative treatments are currently limited. While stem cell transplantation offers therapeutic potential through neural regeneration, this approach is associated with the challenges of limited applicable sources. Hair follicle stem cells (HFSCs) are multipotential cells that can differentiate into ectodermal and mesodermal lineages and proliferate for long periods. The therapeutic potentials of HFSCs have not been investigated in ischaemic stroke models, and therefore, in this study, we aimed to determine whether they could survive and migrate to ischaemic areas after a stroke attack.

Methods

A rat model of middle cerebral artery ischaemia/reperfusion was established and intravenously administered HFSCs. The potential of HFSCs to migrate and differentiate into neuron-like cells as well as their ability to reduce the infarct size was evaluated. Rat brain tissue samples were collected 2 weeks after cell transplantation and analysed via TTC staining, immunofluorescence and immunohistochemistry methods. The data were statistically analysed and presented as the means ± standard deviations.

Results

Intravenously administrated rat HFSCs were able to migrate to the penumbra where they expressed neuron-specific markers, reduced the infarct volume and promoted neurological recovery.

Conclusion

HFSC transplantation has therapeutic potential for ischaemic stroke and is, therefore, worthy of further investigation toward possible clinical development for treating stroke patients.

Background

Ischaemic stroke has become the main cause of disability and death worldwide [1]. The number of patients who can undergo recanalization therapy is restricted because of the strict eligibility criteria and narrow time window [2, 3]. The central nervous system (CNS) can hardly regenerate under pathological conditions, which leads to irreversible neurological disabilities. However, regenerative medicine brings new hope for functional organ reconstruction.

For many CNS diseases, such as spinal cord injury and stroke, stem cell transplantation is a practical regenerative strategy; however, it is associated with inevitable challenges. For example, neural or embryonic stem cells are suitable stem cell sources for CNS diseases; however, they are very sparse and extremely difficult to acquire. In contrast, bone marrow mesenchymal or hemopoietic stem cells, which have been used in many diseases, originate from a different embryo layer than the neural system, and thus, they have limited potential to differentiate into neurons [4, 5]. Moreover, the identified stem cell sources cannot meet the substantial clinical requirements in a short time.

Hair follicle stem cells (HFSCs) can be a highly promising source of multipotent cells, as they are abundant, accessible, and active in adult mammals. Throughout the lifetime, mammals’ hair undergoes a unique regenerative phenomenon consisting of cyclic periods, growth, regression, and rest. The stem cells contained in the hair follicle bulge region have been verified based on several criteria [6]. HFSCs continuously produce new cells to restore follicles and cutaneous appendages during the anagen phase [7] and can differentiate into most mesodermal and ectodermal derivatives [8]. Despite skin diseases, these characteristics make HFSCs a promising cell source for the treatment of nervous system disorders [9].

Stem cells isolated from the rat vibrissa have been shown to differentiate into ectodermal lineages such as neural cells, astrocytes, oligodendrocytes, and Schwann cells when cultured in vitro [10], as well as mesodermal derivatives including myocytes [11], chondrocytes [12], and osteocytes [13]. Interestingly, Robert M. Hoffman proved that after 7 days of culture in RPMI 1640 medium containing 10% FBS, 48 ± 8%, and 30 ± 8% of the population of HFSCs differentiated into neurons and glial cells, respectively [14]. Moreover, HFSCs have been transplanted into skin injury [15, 16], spinal cord injury [17], peripheral nerve injury [6], and Alzheimer’s disease animal models [18], with results indicating their potential to localise to the injury site and promote angiogenesis or neurological functional recovery.

As a promising source of stem cells for ischaemic stroke treatment, HFSCs have three important advantages making them prominent among all stem cells. First, they are abundant and accessible. Second, they are pluripotent, holding the capability to differentiate into both ectodermal and mesodermal lineages. Third, they are active and proliferative for long periods, making it possible for most patients to accept auto-transplantation without ethical or logistic problems. However, HFSCs have not been evaluated in ischaemic stroke models to date, and whether they can survive and migrate to ischaemic areas after a stroke attack is still unclear. Therefore, in the present study, we aimed to investigate this phenomenon using a middle cerebral artery (MCA) ischaemia/reperfusion (I/R) rat model based on immunohistochemical, immunofluorescence and TTC staining assays.

Materials and methods

Experimental design

A total of 48 rats were divided into four groups at random: (i) control, (ii) sham, (iii) I/R + saline and (iv) I/R + HFSCs. Rats in the control group were healthy and not subjected to an operation, whereas the I/R model was established via surgical MCA occlusion (MCAO). In the sham group, rats received a similar operation but without MCA occlusion. The I/R + HFSCs group underwent HFSC transplantation (1 × 106 cells dispersed in 1 mL saline) via tail vein injection 24 h after reperfusion, whereas animals in the I/R + saline group and sham group were similarly administered 1 mL saline.

Animals were maintained for 2 weeks after transplantation, and then, relevant tissue samples from half of the animals were analysed using TTC (Amresco, OH, USA) and the other half were used for histological staining (n = 6 each, Fig. 1). The 2-week survival point was chosen because it might be the shortest time required for the transplanted cells to migrate to the penumbra and exert putative protective effects on stroke recovery. Neurological scores (Table 1) were recorded daily after cell transplantation [19]. The score of each rat was estimated three times. A full score represents a normal neurological status, whereas lower scores are indicative of behavioural deficits.

Fig. 1
figure1

Experiment design and procedure. The rats in sham group and I/R + saline group were treated with 1 mL saline, whereas rats in I/R + HFSC group were administrated with HFSCs (1 × 106 in 1 mL saline) transplantation, 24 h after reperfusion. Behavioural tests were conducted daily after reperfusion until 14 days post-transplantation. TTC staining, immunofluorescence, and immunohistochemistry assays were conducted on day 15

Table 1 Neurological scores system

Animals

Male Sprague-Dawley (S-D) rats weighing 280 ± 10 g were purchased from the animal centre of the Second Affiliated Hospital of Harbin Medical University. The animals were housed at 22 ± 2 °C with a humidity of 40 ± 5%, under a 12-h light/dark cycle, and fed a standard diet and water ad libitum. The rats were forbidden to eat 12 h before the experiments but were allowed free access to drinking water. All study design and experimental procedures were conducted in accordance with institutional guides for animal experiments approved by the Experimental Center of the Second Affiliated Hospital of Harbin Medical University.

Isolation, culture, labelling and transplantation of rat-derived HFSCs

We harvested hair follicles via enzyme digestion following mechanical dissection [20]. The upper lips containing the vibrissa pad of 4-week-old male S-D rats were cut and digested with 0.1% collagenase in DMEM (both from Gibco, BRL, Gaithersburg, MD, USA). Then, the vibrissa follicles were gently plucked from the pad under a binocular microscope, placed in 24-well tissue-culture dishes (Corning, NY, USA) pre-treated with IV collagen, and cultured in DMEM containing 10% FBS (ScienCell, Santiago, CA, USA) and 1% penicillin and streptomycin (Gibco, BRL, Gaithersburg, MD, USA) at 37 °C in an atmosphere of 95% air–5% CO2. All surgical procedures were conducted in accordance with aseptic principles, and the entire culture medium was first replaced with fresh medium 12 h later. The non-adherent cells were discarded with the waste culture medium, and thereafter, the culture medium was replaced every 48 h. When the culture grew to approximately 80% confluency (~ 10 days), the new adherent cells were passaged using the same culture method. The prepared HFSCs were used at passage 3 in the experiments. To monitor the grafted cells in the brain, the HFSCs were pre-labelled by non-invasive membrane-labelling green fluorescent dye PKH 67. Two weeks after HFSC transplantation, the TTC and histological staining were performed.

Induction of focal cerebral I/R

The focal cerebral I/R model was induced by the right MCAO for 1 h following reperfusion, as reported previously [21, 22]. Briefly, after intraperitoneal anesthetisation with compound anaesthetic consisting of 4.25% chloral hydrate and 0.886% pentobarbital sodium (0.3 mL/100 g), a midline ventral incision was made on the neck to expose the vessels. The right external carotid artery (ECA) was isolated, and the branches were cauterised. The right MCA was occluded by gently inserting a monofilament nylon suture with a rounding tip through the right ECA. After a 60-min occlusion, the suture was slowly pulled back to achieve reperfusion. The rats in the sham group received the similar procedure except that the right MCA was not occluded. The body temperature was maintained at 37 ± 5 °C using a thermostat-controlled heating pad from the start of the operation until the animals recovered from anaesthesia.

TTC staining

To measure the infarct volume, TTC staining was carried out as described previously [23]. Briefly, brain tissue was cut into five coronal slices (2-mm thick) and incubated in 1% TTC dissolved in PBS for 15 min at 37 °C. The non-infarcted tissue was stained red, whereas the infarcted tissue area remained white. The infarct volume was calculated as follows: [(left hemisphere area − right non-infarcted area)/(left hemisphere area × 2)] to avoid the influence of oedema [24].

Nissl staining

Following anaesthesia, rats were transcardially perfused with 0.9% saline until no blood flowed out, followed by 4% paraformaldehyde in PBS (pH 7.4). The brain tissue was removed and kept in 4% paraformaldehyde for 48 h, cryoprotected in 30% sucrose in PBS for another 48 h at 4 °C and then embedded in OCT compound (Sakura Finetek, Torrance, CA, USA). The brain specimens were cut into coronal slices at a 10-μm thickness between the optic chiasma and the cerebral caudal end using a cryostat machine (Thermo Scientific Microm HM560, Waltham, MA, USA). The sections were then air-dried and processed for pathological experiments, including Nissl staining. Nissl bodies were stained using Cresyl violet acetate (Sigma-Aldrich, St Louis, MO, USA). Briefly, the brain tissue slices were immersed in the Cresyl violet acetate solution for 2 h at 37 °C, successively dehydrated and hyalinised, and observed under an optical microscope [21].

Immunofluorescence

Frozen sections were blocked with 5% goat serum (Cat. No. abs933, Absin, Shanghai, China) in PBS for 30 min and incubated with primary rabbit anti-doublecortin (Cat. No. ab18723, DCX, Abcam, Cambridge, UK), mouse anti-neuron-specific nuclear protein (Cat. No. MAB377, NeuN, Millipore Corp, Billerica, MA, USA) antibodies overnight at 4 °C. After rinsing with PBS, the sections were incubated with rhodamine-conjugated anti-rabbit IgG (1:500, Cat. No. 4413S, Cell Signalling Technology, VT, USA) or anti-mouse IgG (1:500, Cat. No. 4409S, Cell Signalling Technology, VT, USA) for 90 min at 25 °C. The nuclei were stained with DAPI. PKH 67 (green), neuron-specific markers (red) and DAPI (blue) were observed using laser scanning confocal microscopy (Zeiss LSM800; Carl Zeiss, Jena, Germany) at wavelengths of 594 nm (red), 488 nm (green) and 405 nm (blue), respectively.

Immunohistochemistry

The brain sections were incubated with 0.3% H2O2 to eliminate endogenous peroxidase, blocked with 10% goat serum and treated with 0.1% triton X-100 in PBS for 30 min at 25 °C. Then, the sections were incubated with rabbit anti-DCX, mouse anti-NeuN antibodies overnight at 4 °C. After washing with PBS, the sections were incubated with horseradish peroxidase-linked anti-rabbit or anti-mouse IgG (1:500, Cell Signalling Technology, VT, USA) for 60 min at 25 °C and stained with DAB (Cell Signalling Technology, VT, USA). The sections were rinsed with PBS, counterstained with haematoxylin, then dehydrated and observed using an optical microscope.

Statistical analysis

The statistical analysis was performed using GraphPad Prism 6.0 (GraphPad Prism Software, San Diego, CA, USA). The data were analysed using one-way ANOVA, followed by Tukey’s test for multiple comparisons and Student’s t test for two group comparisons. Values with P < 0.05 were considered statistically significant. All data are expressed as means ± standard deviations (SDs).

Results

Characteristics of HFSCs

The self-renewable HFSCs exhibited colony formation, plastic adherence and a paving stone-like morphology (Fig. 2a–c). The capacity of multipotent differentiation was verified by osteogenesis and adipogenesis experiments (Fig. 2d, e). The image of PKH-67-pre-labelled HFSCs under a fluorescence microscope is presented in Fig. 2f. The expression of mesenchymal stem cell surface markers was detected by fluorescence-activated cell sorting (FACS) (BD FACS Canto II, NJ, USA) analyses (Fig. 3). In conclusion, the cells derived from S-D rat hair follicle vibrissa appeared to be largely HFSCs.

Fig. 2
figure2

Identification of hair follicle stem cells. a P0: Primary HFSCs started to form colonies 7–10 days and attached to the plate surface. b, c P1 and P3: HFSCs displayed triangular and paving stone-like morphology. d, e Multilineage differentiation of HFSC: mineralised nodules and fat droplets. f PKH67-labelled HFSCs emitted green fluorescence under fluorescence microscope. The nuclei were stained blue with DAPI. Scale bar = 50 μm

Fig. 3
figure3

Fluorescence-activated cell sorting (FACS) of HFSCs. CD29 and CD90 are surface markers of mesenchymal stem cells. CD31and CD45 are the surface antigens of endothelial cells and leucocytes, respectively. The cultured HFSCs mainly expressed CD29 and CD90, rarely expressed CD31and CD45

Focal cerebral I/R rat model

TTC staining and Nissl staining were used to confirm and analyse the successful establishment of the focal cerebral I/R model along with neurological system scores. A white zone within the brain tissue slices represented the infarcted area caused by I/R injury, whereas the red zone represented normal brain tissue (Fig. 4a, b). Nissl staining (Fig. 4c, d) showed significant damage to neurons in the infarcted area. Neurons in the healthy area exhibited normal morphological features, whereas those in the infarcted area showed several impaired features such as cell loss, nuclear karyorrhexis, and pyknosis.

Fig. 4
figure4

MCAO modelling assessment. a Consecutive coronal slices of sham operated rats. Scale bar = 20 mm. b Serial coronal slices of MCAO rats. Typical photographs of rat brain stained with 2,3,5-triphenyltetrazolium chloride (TTC), wherein no infarction tissue was stained red, whereas the infarction area remained white. Scale bar = 20 mm. c, d Nissl staining of MCAO models revealed lesions in the brain tissues, with diminished numbers of neurons and chaotic neuronal configuration. Scale bar = 5 mm (c) and 1.5 mm (d). e, f Enlargement of healthy area and infarcted area. The black arrow indicates Nissl-positive neurons. The double arrows indicate nuclear pyknosis with karyorrhexis. Scale bar = 100 μm

HFSCs migrate to ischaemic penumbra

The spatial distribution of HFSCs within the brain was monitored and analysed after transplantation into the cerebral I/R model. The green fluorescent dye-pre-labelled HFSCs were easily identified using a fluorescent microscope (Fig. 5). Figure 5a, c shows the regions of the non-infarcted hemisphere, whereas images of the I/R-insulted tissue are presented in Fig. 5b, d. PKH 67-labelled HFSCs were visibly localised to the penumbra area, but rarely found in the normal hemisphere.

Fig. 5
figure5

PKH67-labelled hair follicle stem cells (HFSCs) present in the penumbra. a, c Different regions of contralateral hemisphere of I/R. b, d Typical regions of the hemisphere with I/R injury. Majority of PKH67-labelled HFSCs gathered around the ischemic area, but rarely migrated to the contralateral hemisphere. Scale bar = 1 mm

Grafted HFSCs express neuron-specific markers

The co-localisation of PKH 67-pre-labelled HFSCs and neuron-specific markers was evaluated by laser scanning confocal microscopy. Cell tracker PKH 67 emitted green fluorescent signals both in vitro and in vivo. Immunolabelling of neural-specific markers conjugated with red fluorescent indicator was used to detect the differentiation activity of HFSCs in the I/R model. As shown in Fig. 6, PKH 67-labelled cells located at the penumbra region could express the neuron-specific markers DCX and NeuN, whereas DAPI stained the nuclei blue.

Fig. 6
figure6

HFSCs in the penumbra express neuron-specific markers including doublecortin (DCX) and neuron-specific nuclear protein (NeuN). a, f PKH-67-labelled HFSCs emitted green fluorescence in the penumbra. b, g The neuron-specific markers with Alexa Fluor® 594-conjugated secondary antibodies emitted red fluorescence. c, h DAPI staining emitted blue fluorescence at the wavelength of 405 nm. d, i PKH67-labelled HFSCs were overlayed with the panel of neuron-specific markers and DAPI. Scale bar = 50 μm. e, j The magnified typical image of co-localised cells. Scale bar = 10 μm

Neuron-specific marker expression in penumbra

Immunohistochemistry staining was conducted to analyse the number of neurons in the penumbra regions. Figure 7 shows the number of neuron-specific marker-positive cells around the ischaemic core. The number of DCX-positive cells increased in the I/R + saline group compared with the sham group, while HFSC treatment enhanced the expression of DCX after I/R injury (P < 0.05). The number of NeuN-positive cells decreased in the I/R + saline group compared with that in the sham group, whereas these decreases were significantly inhibited by HFSC treatment (P < 0.05).

Fig. 7
figure7

The expression of neuron-specific markers DCX and NeuN in the penumbra. a–h The representative photographs of neuron-specific markers expression in all groups. Scale bar = 25 μm. i, j The quantitation of the neuron specific markers positive cells. The number of positive cells was upregulated in HFSC group compared with I/R + saline group by immunohistochemistry assay. Values are the mean ± SD. *P < 0.05 vs. sham group, #P < 0.05 vs. I/R group, (n = 6)

HFSCs reduce infarct volume and improve neurological scores

To investigate whether intravenously transplanted HFSCs could alleviate damage in the cerebral I/R model, TTC staining was conducted to measure the infarct volume 2 weeks after cell transplantation (Fig. 8). The TTC staining photographs of the I/R groups are exhibited in Fig. 8a, where the red and white colours indicate non-infarcted and infarcted tissue, respectively. Compared to that in the I/R + saline group, the I/R + HFSCs group showed a significant reduction in I/R-induced cerebral infarction.

Fig. 8
figure8

The effect of HFSCs on brain infarction and neurological scores. a Representative photographs of rat brain stained with TTC in different groups. Scale bar = 20 mm. b Quantitative analysis of infarct size in all groups, showing that infarct volume in saline group is about 44.20 ± 2.16%, whereas the HFSC transplantation group is to 29.80 ± 1.86%. c Neurological scores of animals in different groups. Values are the mean ± SD. *P < 0.05 vs. sham group, #P < 0.05 vs. I/R group, (n = 6)

Quantitation of the cerebral infarct volume showed that the proportion was 44.20 ± 2.16% in the I/R + saline group, whereas in the I/R + HFSCs group, the white zone was significantly smaller at 29.80 ± 1.86% (P < 0.05) (Fig. 8b). The neurological score indicated that the rats in the I/R + saline group underwent slow recovery from neurological deficits induced by I/R injury, whereas HFSC transplantation obviously improved neurological functional recovery (P < 0.05) (Fig. 8c).

Discussion

In this study, we demonstrated that transvenously grafted rat HFSCs could survive in a cerebral I/R rat and migrate to the ischaemic boundary zone. Moreover, most PKH67-labelled HFSCs expressed the neuron-specific cell markers DCX and NeuN in the penumbra area. Furthermore, HFSC injection exerted a protective effect on I/R-induced brain injury by reducing the infarct volume and enhancing neurological functional recovery. These phenomena suggested that HFSCs could be a novel alternative source for ischaemic stroke regenerative treatment with remarkably appealing potential.

Stem cell transplantation, as a promising therapeutic approach in stroke diseases, has been investigated for many years in numerous studies [25]. However, obtaining an optimal cell source has been challenging. HFSCs are considered an outstanding candidate among different stem cells because of their attractive characteristics such as abundance, easy accessibility, low invasiveness, multipotency, and auto-transplantability with no ethical or logistical problems.

Since HFSCs have not been investigated in a cerebral I/R rat model, we prudently considered the administration route and transplantation time window. Firstly, intravenous infusion, compared with other administration routes such as intraarterial or intraventricular routes, is more suitable for the administration of stem cells, with the least invasive injury or risk of thrombosis. In the present study intravenous administration proved to be a safe and effective approach and could be a practical method for the clinical application of these findings. Secondly, an optimal time point for transplanted stem cell survival after a stroke exists before the maximal activation of the microglia [26]. In a stroke rat model, the corresponding time window would be within 2–3 days after the insult, which is when the maximum accumulation of macrophages is observed [27]. For this reason, we chose to conduct HFSC transplantation 24 h after reperfusion. Thirdly, the HFSCs differentiated into neural class III β-tubulin-positive and CD31-negative neurons 2 weeks after transplantation into nude mice [14]. Thus, in the present study, the brain tissue was collected 2 weeks after cell transplantation. DCX, a valuable marker of immature neuron, has been used to detect neurogenesis [28]. NeuN is usually used to mark mature neurons [29, 30]. Our study demonstrated that 2 weeks after transplantation into the cerebral I/R rat model, HFSCs migrated to the ischaemic penumbra and expressed neuron-specific cell markers (Fig. 6), as expected.

We first verified the homing capability of HFSCs in a cerebral I/R rat model after intravenous administration. Studies have reported that homing mechanisms of stem cells, including HFSCs, to sites of ischaemia requires a coordinated multistep process, including recruitment of stem cells, adhesion to the endothelium, transendothelial migration, matrix degradation and invasion, and in situ differentiation [31,32,33]. Stromal cell-derived factor 1 (SDF-1) and its receptor C-X-C motif chemokine receptor 4 (CXCR4) play vital roles as the drivers of stem cells homing [34, 35]. A recent study suggests that platelets participate in metastasis and homing of stem cells by spatial approach and direct contact, which indicates a new main source of homing-related factors [36, 37]. In the present study, we focused on elucidating the cell homing phenomenon by performing pathological experiments. The cytokines and factors involved in HFSC homing after transplantation into I/R rats thus require further study.

Transplanted mesenchymal stem cells possess the potential to differentiate into neurons [38]. The results showed that the grafted HFSCs in the penumbra expressed neuron-specific markers, thereby indicating that they might differentiate into neuron-like cells such as immature neurons expressing DCX or mature neuron expressing NeuN (Fig. 6). Stem cell differentiation might partially account for the increase in neuron-specific marker-positive cells in the HFSC group (Fig. 7). Additionally, many studies have reported that stem cells contribute to neuroprotection via pro-angiogenesis [39, 40], pro-neurogenesis [41], anti-inflammation and anti-apoptosis [42] mechanisms in I/R injury, which could be concluded to represent paracrine effects. Recently, co-culture studies in vitro using a transwell set-up have revealed that mesenchymal stem cells alleviate acute lung injury via paracrine effect of hepatocyte growth factor [43]. Moreover, FGF-2-modified human gingival mesenchymal stem cells have been verified to promote angiogenesis via paracrine effects of angiogenesis-related growth factors [44]. Besides, HFSCs have been demonstrated to possess neuroendocrinology [45] and ability to promote recovery of peripheral nerve injury by paracrine effects [46]. Thus, combined with the results of the present study, the neural protection effects induced by HFSCs might be partially mediated via their paracrine ability, but further studies are needed to confirm this hypothesis. What can be verified from our study is that HFSC transplantation reduced neuron loss and the infarct volume and improved neurological recovery (Fig. 8).

Conclusions

In conclusion, our results illustrate a homing phenomenon in which transvenously grafted HFSCs localised around the ischaemic regions, without requiring a blood–brain barrier permeabilizer, and expressed neuron-specific cell markers. Moreover, HFSCs exhibited therapeutic effects by reducing the infarct volume and promoting neurological functional recovery, which require more fundamental studies to illuminate the underlying mechanisms before application in a clinical setting.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Abbreviations

HFSCs:

Hair follicle stem cells

I/R:

Ischaemia/reperfusion

MCAO:

Middle cerebral artery occlusion

References

  1. 1.

    Ekker MS, Verhoeven JI, Vaartjes I, Jolink WMT, Klijn CJM, de Leeuw FE. Association of stroke among adults aged 18 to 49 years with long-term mortality. Jama. 2019;321(21):2113–23.

    PubMed  PubMed Central  Article  Google Scholar 

  2. 2.

    Wright AC, Muir L. A review of published radiographic indicators of carpometacarpal dislocation including their application to volar dislocations through a case study. J Emergency Med. 2015;49(3):e69–71.

    Article  Google Scholar 

  3. 3.

    Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372(11):1009–18.

    PubMed  Article  CAS  Google Scholar 

  4. 4.

    Wu Y, Wu J, Ju R, Chen Z, Xu Q. Comparison of intracerebral transplantation effects of different stem cells on rodent stroke models. Cell Biochem Funct. 2015;33(4):174–82.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  5. 5.

    Geranmayeh MH, Nourazarian A, Avci ÇB, Rahbarghazi R, Farhoudi M. Stem cells as a promising tool for the restoration of brain neurovascular unit and angiogenic orientation. Mol Neurobiol. 2017;54(10):7689–705.

    PubMed  Article  CAS  Google Scholar 

  6. 6.

    Amoh Y, Li L, Campillo R, Kawahara K, Katsuoka K, Penman S, et al. Implanted hair follicle stem cells form Schwann cells that support repair of severed peripheral nerves. Proc Natl Acad Sci U S A. 2005;102(49):17734–8.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  7. 7.

    Wilson C, Cotsarelis G, Wei ZG, Fryer E, Margolis-Fryer J, Ostead M, et al. Cells within the bulge region of mouse hair follicle transiently proliferate during early anagen: heterogeneity and functional differences of various hair cycles. Differentiation Research Biol Diversity. 1994;55(2):127–36.

    Article  CAS  Google Scholar 

  8. 8.

    Blanpain C, Lowry WE, Geoghegan A, Polak L, Fuchs E. Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell. 2004;118(5):635–48.

    PubMed  Article  CAS  Google Scholar 

  9. 9.

    Kanno H. Regenerative therapy for neuronal diseases with transplantation of somatic stem cells. World J Stem Cells. 2013;5(4):163–71.

    PubMed  PubMed Central  Article  Google Scholar 

  10. 10.

    El Seady R, Huisman MA, Löwik CW, Frijns JH. Uncomplicated differentiation of stem cells into bipolar neurons and myelinating glia. Biochem Biophys Res Commun. 2008;376(2):358–62.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  11. 11.

    Yu H, Fang D, Kumar SM, Li L, Nguyen TK, Acs G, et al. Isolation of a novel population of multipotent adult stem cells from human hair follicles. Am J Pathol. 2006;168(6):1879–88.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  12. 12.

    Sieber-Blum M, Grim M, Hu YF, Szeder V. Pluripotent neural crest stem cells in the adult hair follicle. Developmental Dynamics. 2004;231(2):258–69.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  13. 13.

    Yu H, Kumar SM, Kossenkov AV, Showe L, Xu X. Stem cells with neural crest characteristics derived from the bulge region of cultured human hair follicles. J Investigative Dermatol. 2010;130(5):1227–36.

    Article  CAS  Google Scholar 

  14. 14.

    Amoh Y, Li L, Katsuoka K, Penman S, Hoffman RM. Multipotent nestin-positive, keratin-negative hair-follicle bulge stem cells can form neurons. Proc Natl Acad Sci U S A. 2005;102(15):5530–4.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  15. 15.

    Amoh Y, Li L, Yang M, Moossa AR, Katsuoka K, Penman S, et al. Nascent blood vessels in the skin arise from nestin-expressing hair-follicle cells. Proc Natl Acad Sci U S A. 2004;101(36):13291–5.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  16. 16.

    Quan R, Du W, Zheng X, Xu S, Li Q, Ji X, et al. VEGF165 induces differentiation of hair follicle stem cells into endothelial cells and plays a role in in vivo angiogenesis. J Cell Mol Med. 2017;21(8):1593–604.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  17. 17.

    Najafzadeh N, Nobakht M, Pourheydar B, Golmohammadi MG. Rat hair follicle stem cells differentiate and promote recovery following spinal cord injury. Neural Regen Res. 2013;8(36):3365–72.

    PubMed  PubMed Central  Google Scholar 

  18. 18.

    Esmaeilzade B, Nobakht M, Joghataei MT, Rahbar Roshandel N, Rasouli H, Samadi Kuchaksaraei A, et al. Delivery of epidermal neural crest stem cells (EPI-NCSC) to hippocamp in Alzheimer’s disease rat model. Iran Biomed J. 2012;16(1):1–9.

    PubMed  PubMed Central  CAS  Google Scholar 

  19. 19.

    Garcia JH, Wagner S, Liu KF, Hu XJ. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke. 1995;26(4):627–34 discussion 35.

    PubMed  Article  CAS  Google Scholar 

  20. 20.

    Kajiura S, Mii S, Aki R, Hamada Y, Arakawa N, Kawahara K, et al. Protocols for cryopreservation of intact hair follicle that maintain pluripotency of nestin-expressing hair-follicle-associated pluripotent (hap) stem cells. Methods in molecular biology (Clifton, NJ). 2016;1453:173–8.

    Article  CAS  Google Scholar 

  21. 21.

    Tang H, Pan CS, Mao XW, Liu YY, Yan L, Zhou CM, et al. Role of NADPH oxidase in total salvianolic acid injection attenuating ischemia-reperfusion impaired cerebral microcirculation and neurons: implication of AMPK/Akt/PKC. Microcirculation (New York, NY : 1994). 2014;21(7):615–27.

  22. 22.

    Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20(1):84–91.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  23. 23.

    Wicha P, Tocharus J, Janyou A, Jittiwat J, Chaichompoo W, Suksamrarn A, et al. Hexahydrocurcumin alleviated blood-brain barrier dysfunction in cerebral ischemia/reperfusion rats. Pharmacological reports: PR. 2020.

  24. 24.

    Gao D, Zhang X, Jiang X, Peng Y, Huang W, Cheng G, et al. Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice. Life Sci. 2006;78(22):2564–70.

    PubMed  Article  CAS  Google Scholar 

  25. 25.

    Hao L, Zou Z, Tian H, Zhang Y, Zhou H, Liu L. Stem cell-based therapies for ischemic stroke. Biomed Res Int. 2014;2014:468748.

    PubMed  PubMed Central  Google Scholar 

  26. 26.

    Darsalia V, Allison SJ, Cusulin C, Monni E, Kuzdas D, Kallur T, et al. Cell number and timing of transplantation determine survival of human neural stem cell grafts in stroke-damaged rat brain. J Cerebral Blood Flow Metabolism. 2011;31(1):235–42.

    Article  Google Scholar 

  27. 27.

    Lalancette-Hébert M, Gowing G, Simard A, Weng YC, Kriz J. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci. 2007;27(10):2596–605.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  28. 28.

    Le Maître TW, Dhanabalan G, Bogdanovic N, Alkass K, Druid H. Effects of alcohol abuse on proliferating cells, stem/progenitor cells, and immature neurons in the adult human hippocampus. Neuropsychopharmacol. 2018;43(4):690–9.

    Article  CAS  Google Scholar 

  29. 29.

    Duan W, Zhang YP, Hou Z, Huang C, Zhu H, Zhang CQ, et al. Novel insights into NeuN: from neuronal marker to splicing regulator. Mol Neurobiol. 2016;53(3):1637–47.

    PubMed  Article  CAS  Google Scholar 

  30. 30.

    Doeppner TR, Herz J, Görgens A, Schlechter J, Ludwig AK, Radtke S, et al. Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression. Stem Cells Transl Med. 2015;4(10):1131–43.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  31. 31.

    Tao Z, Tan S, Chen W, Chen X. Stem cell homing: a potential therapeutic strategy unproven for treatment of myocardial injury. J Cardiovasc Transl Res. 2018;11(5):403–11.

    PubMed  Article  Google Scholar 

  32. 32.

    Chavakis E, Urbich C, Dimmeler S. Homing and engraftment of progenitor cells: a prerequisite for cell therapy. J Mol Cell Cardiol. 2008;45(4):514–22.

    PubMed  Article  CAS  Google Scholar 

  33. 33.

    Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation. 2004;110(21):3300–5.

    PubMed  Article  PubMed Central  Google Scholar 

  34. 34.

    Würth R, Bajetto A, Harrison JK, Barbieri F, Florio T. CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment. Front Cell Neurosci. 2014;8:144.

    PubMed  PubMed Central  Google Scholar 

  35. 35.

    Yu Y, Wu RX, Gao LN, Xia Y, Tang HN, Chen FM. Stromal cell-derived factor-1-directed bone marrow mesenchymal stem cell migration in response to inflammatory and/or hypoxic stimuli. Cell Adhes Migr. 2016;10(4):342–59.

    Article  CAS  Google Scholar 

  36. 36.

    Naderi-Meshkin H, Ahmadiankia N. Cancer metastasis versus stem cell homing: role of platelets. J Cell Physiol. 2018;233(12):9167–78.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  37. 37.

    Liang C, Huang J, Luo P, Wang Z, He J, Wu S, et al. Platelet-derived microparticles mediate the intra-articular homing of mesenchymal stem cells in early-stage cartilage lesions. Stem Cells Dev. 2020.

  38. 38.

    Fandel TM, Trivedi A, Nicholas CR, Zhang H, Chen J, Martinez AF, et al. Transplanted human stem cell-derived interneuron precursors mitigate mouse bladder dysfunction and central neuropathic pain after spinal cord injury. Cell Stem Cell. 2016;19(4):544–57.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  39. 39.

    Sowa K, Nito C, Nakajima M, Suda S, Nishiyama Y, Sakamoto Y, et al. Impact of dental pulp stem cells overexpressing hepatocyte growth factor after cerebral ischemia/reperfusion in rats. Molecular Therapy Methods Clin Development. 2018;10:281–90.

    Article  CAS  Google Scholar 

  40. 40.

    Cheng Z, Wang L, Qu M, Liang H, Li W, Li Y, et al. Mesenchymal stem cells attenuate blood-brain barrier leakage after cerebral ischemia in mice. J Neuroinflammation. 2018;15(1):135.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  41. 41.

    Zhang P, Li J, Liu Y, Chen X, Lu H, Kang Q, et al. Human embryonic neural stem cell transplantation increases subventricular zone cell proliferation and promotes peri-infarct angiogenesis after focal cerebral ischemia. Neuropathol. 2011;31(4):384–91.

    Article  Google Scholar 

  42. 42.

    Stonesifer C, Corey S, Ghanekar S, Diamandis Z, Acosta SA, Borlongan CV. Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms. Prog Neurobiol. 2017;158:94–131.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  43. 43.

    Lu Z, Chang W, Meng S, Xu X, Xie J, Guo F, et al. Mesenchymal stem cells induce dendritic cell immune tolerance via paracrine hepatocyte growth factor to alleviate acute lung injury. Stem Cell Res Ther. 2019;10(1):372.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  44. 44.

    Jin S, Yang C, Huang J, Liu L, Zhang Y, Li S, et al. Conditioned medium derived from FGF-2-modified GMSCs enhances migration and angiogenesis of human umbilical vein endothelial cells. Stem Cell Res Ther. 2020;11(1):68.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  45. 45.

    Paus R, Langan EA, Vidali S, Ramot Y, Andersen B. Neuroendocrinology of the hair follicle: principles and clinical perspectives. Trends Mol Med. 2014;20(10):559–70.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  46. 46.

    Yamazaki A, Obara K, Tohgi N, Shirai K, Mii S, Hamada Y, et al. Implanted hair-follicle-associated pluripotent (HAP) stem cells encapsulated in polyvinylidene fluoride membrane cylinders promote effective recovery of peripheral nerve injury. Cell Cycle. 2017;16(20):1927–32.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank Dr. Shaohong Fang from the Key Laboratory of Myocardial Ischaemia, at the Harbin Medical University, for her help in the pathological studies and the confocal microscope. We would also like to acknowledge Dr. Zhaoying Li from the Key Laboratory of Myocardial Ischaemia for her assistance with the HFSC characterisation and the flow cytometric analysis.

Funding

This work was supported by the Fundamental Research Funds for the Provincial Universities.

Author information

Affiliations

Authors

Contributions

XZ contributed to the methodology development. HT performed the experiments, carried out the statistical analyses, and wrote the manuscript. SM contributed to the background investigation, data acquisition, and manuscript revision. BL and YZ took the photos and videos. HY was responsible for the software analysis. DW took care of the animals. YW validated the data. JF designed the project, supervised the study, and wrote and revised the manuscript. The authors read and approved the final manuscript.

Corresponding author

Correspondence to Jin Fu.

Ethics declarations

Ethics approval and consent to participate

All experimental procedures were conducted in accordance with the relevant ethical guidelines and regulations approved by the Experimental Center of the Second Affiliated Hospital of Harbin Medical University.

Consent for publication

Not applicable.

Competing interests

All authors declare that they have no conflicts of interest regarding this study.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhang, X., Tang, H., Mao, S. et al. Transplanted hair follicle stem cells migrate to the penumbra and express neural markers in a rat model of cerebral ischaemia/reperfusion. Stem Cell Res Ther 11, 413 (2020). https://doi.org/10.1186/s13287-020-01927-w

Download citation

Keywords

  • Hair follicle stem cells
  • Ischaemia/reperfusion
  • Cell transplantation
  • Homing
  • Differentiation